D

HEALTHPEAK PROPERTIES, INC.

DOC NYSE Real Estate · REIT—Diversified Denver, CO www.healthpeak.com
$21.47
Mkt Cap 14.80B
Overview Healthpeak Properties, Inc. is a Standard & Poor’s ( S&P ) 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United St…

Overview Healthpeak Properties, Inc. is a Standard & Poor’s ( S&P ) 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States ( U.S. ). Our company was originally founded in 1985. We are organized as an umbrella partnership REIT ( UPREIT ). We hold substantially all of our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member. We are a Maryland corporation and qualify as a self-administered REIT. We are headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices in several locations throughout the U.S. We have a diversified portfolio of high-quality healthcare properties across three core asset classes of outpatient medical, lab, and senior housing real estate. Under the outpatient medical and lab segments, we own, operate, and develop outpatient medical buildings, hospitals, and lab buildings. Under the senior housing segment, our properties are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of: (i) loans receivable, (ii) a preferred equity investment, and (iii) three other properties . These non-reportable segments have been p resented on a combined basis herein. On March 1, 2024 (the Closing Date ), we completed our merger with Physicians Realty Trust (the Merger ). Subsequent to the Closing Date, the Combined Company means Healthpeak and its subsidiaries.

/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$2.87B
FCF TTM
$1.18B
P/E RATIO
66.6x
P/FCF
12.5x
Running full 6-factor analysis…